1 prilosec label comprehension study karen lechter, j.d., ph.d. division of drug marketing,...

18
1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

Upload: dwight-gordon

Post on 31-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

1

Prilosec Label Comprehension Study

Karen Lechter, J.D., Ph.D.

Division of Drug Marketing, Advertising, and Communications

Page 2: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

2

Purpose of Label Comprehension Studies

21 CFR 330.10(a)(4)(v)

[OTC labels shall be written] in such terms as to render them likely to be read and understood by the ordinary individual, including individuals of low comprehension, under customary conditions of purchase and use.

Page 3: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

3

Main Study Characteristics

• Mall intercept• N=504• Male and female >age 18

Page 4: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

4

Main Study Characteristics

4 cohorts:

1. heartburn sufferers (N=197)

2. heartburn non-sufferers (N=104)

3. low literate (<8th grade reading)

[N (sufferers) =101; N (non-sufferers) =54)]

4. must ask doctor before use (N=117)--take certain meds., pregnant, nursing

Page 5: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

5

Product Purpose

When asked purpose of product:

• 99% prevention or relief or both

– 65% relief

– 18% prevention

– 16% prevention and relief

Label says prevention and relief

Page 6: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

6

Do Consumers Understand?

• What to do after 14 days of use (83%)

• What to do if trouble swallowing (81%)

• When take to prevent if expect stress (80%)

• When take to prevent if expect meal (83%)

– Low literate (75%)

• If can take 2 within 24 hours (2 Q’s)

(81%, 83%) – Low literate (74%, 81%)

Page 7: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

7

Troubling Result

• 74% of cohort 4 (should see doctor before use) incorrectly said they would use the product to prevent and relieve (2Q’s)

• 21% correct--would not use

Page 8: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

8

Addendum Study

• Does wording of question about self-use in cohort 4 contribute to incorrect responses?

• Compared responses to original self-use question with new self-use question

• N=58 (29 in each arm)• All should ask doctor before use:

– pregnant, nursing, taking certain drugs

Page 9: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

9

Addendum Study Questions

Original questions: If you wanted to prevent/relieve heartburn, would you use Prilosec 1 yourself?

New questions: If you were a heartburn sufferer and you wanted to prevent/relieve heartburn, would it be okay for you (,personally,) to use Prilosec 1 yourself, or not?

Page 10: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

10

Addendum Study Results

% correct

prevention relief

Original Question 35% 31%

Reworded Question 69% 59%

Even with the reworded question, comprehension is low

Page 11: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

11

Additional Addendum Study Questions

If prior response is incorrect:

• Is there anything you would do prior to taking this product, or not?

If prior response is incorrect:

• Considering your current health and medications you are currently taking, would it be necessary for you to contact a doctor prior to using this product yourself, or not?

Page 12: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

12

Additional Addendum Study Questions

If prior response is incorrect:• Are you currently taking any of the following

medications? diazepam, warfarin, phenytoin

If prior response is incorrect:• Are you currently taking any of the following

medications? Valium, Coumadin, Dilantin

Results of leading questions have uncertain value

Page 13: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

13

Addendum Study Conclusions

• Group that should consult with physician before use demonstrates problems in both studies

• 59%-69% correct responses to new question

Page 14: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

14

Tested Label vs. NDA Label

• Label changed substantially after label comprehension test

• New label not tested

Page 15: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

15

Tested Label vs. NDA Label

NDA label added – Causes of symptoms for prevention– Allergy warning– “Do not use” section– Do not use with acid reducers– New drugs to ask about– Wording about taking for prevention– Amount of water to drink

Page 16: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

16

Tested Label vs. NDA Label

NDA label• Specified # days after which see doctor• Changed 14 day limit to 10 days• Ask pharmacist as well as doctor about drugs• Changed wording: trouble swallowing,

pregnancy, directions, storage instructions• Reversed--relief and prevention indications

and directions• Bolded and added warning symbol to

instruction not to take more than 10 days

Page 17: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

17

NDA Label

NDA Label was not tested

Page 18: 1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

18

Summary

• Consumers associate product with relief – 65% said it is for relief

• Data suggest potential for substantial use by persons who should consult doctor first

• Some information is not strongly communicated

• Most recent label not tested– Differs significantly from tested label